D
Mineralys Therapeutics, Inc. MLYS
$14.89 $0.2751.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 8.47M 6.57M 7.20M 6.12M 5.90M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 46.75M 44.45M 51.77M 60.11M 45.17M
Operating Income -46.75M -44.45M -51.77M -60.11M -45.17M
Income Before Tax -43.27M -42.21M -48.95M -56.34M -41.01M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -43.27M -42.21M -48.95M -56.34M -41.01M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -43.27M -42.21M -48.95M -56.34M -41.01M
EBIT -46.75M -44.45M -51.77M -60.11M -45.17M
EBITDA -46.73M -44.43M -51.75M -60.10M -45.16M
EPS Basic -0.66 -0.79 -0.98 -1.13 -0.83
Normalized Basic EPS -0.41 -0.50 -0.61 -0.71 -0.52
EPS Diluted -0.66 -0.79 -0.98 -1.13 -0.83
Normalized Diluted EPS -0.41 -0.50 -0.61 -0.71 -0.52
Average Basic Shares Outstanding 65.45M 53.16M 49.96M 49.82M 49.36M
Average Diluted Shares Outstanding 65.45M 53.16M 49.96M 49.82M 49.36M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --